Forbs Says: " we assume that the stock will move closer to this multiple, we arrive at a price estimate of CAD 13.50 per share for Aphria, which is roughly 12% higher than its current market price."
https://www.forbes.com/sites/greatspeculations/2018/06/13/heres-why-we-believe-that-medical-marijuana-stock-aphria-is-undervalued/#7ace2b884757
Wednesday, June 13, 2018
Forbes says they calculate a target of $13.50 per share for Aphria,
Contact iiroc Surveillance
Market Surveillance (All other markets) | surveillance@iiroc.ca |
Investors are encouraged to direct all general questions, including inquiries about making a complaint, to our dedicated Complaints & Inquiries team toll-free at 1-877-442-4322 or email us at InvestorInquiries@iiroc.ca. IIROC records all calls to and from Complaints & Inquiries team telephone lines.
More information is available in our Investors section of the website which has a special section on
Click Here To Make A Complaint
Click Here To Make A Complaint
Learn more about our Whistleblower service.
Contact This Regulator And Complain- They MUST Review This Stock
|
Subscribe to:
Posts (Atom)